Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCPWG) joint meeting

• Date:
  Wednesday, 27 February 2013, All day
• Location:
  European Medicines Agency, Amsterdam, the Netherlands

This is a joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. The participants are discussing issues in relation to their general involvement in the Agency's activities, giving particular focus to the communication on safety referrals and risk communication, the implementation of the new pharmacovigilance legislation and falsified medicines.

Documents

Agenda - Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCPWG) joint meeting - February 2013

Draft Reference Number: EMA/810501/2012

Minutes of the Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCPWG) joint meeting - February 2013

Adopted Reference Number: EMA/228576/2013

List of participants - Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCPWG) joint meeting - February 2013

Reference Number: EMA/50881/2013

Presentation - How we communicate the outcome of safety reviews (Rebecca Harding)

Presentation - Involvement of patients' and consumers' organisations and healthcare professionals in safety communications (Nathalie Bere, Ivana Silva)

Presentation - Risk communication in a more transparent regulatory environment (Frederic Bouder)

Presentation - Transparency and risk communication: Feedback from the Ditchley Group (David H.-U. Haerry)

Presentation - Focussing on risk communication: Why now? What next? - Global lessons learnt from the Drug Safety theme edition (Priya Bahri)

Presentation - European Union regulatory workshop on medication errors (Thomas Goedecke)

Presentation - Additional monitoring of medicinal products – update of the implementation (Alexios Skarlatos)

Presentation - Communication of additional monitoring

Presentation - Feedback from teleconference on handling of conflicts of interest for patients' and consumers' organisations

Presentation - Involvement of children and young people in the Paediatric Committee activities (Elin Haf Davies)

Presentation - Scientific advice, protocol assistance and patient representatives (Jane Moseley)

Presentation - Preparing patients' representatives for protocol assistance (Maria Mavris)

Presentation - Proactive publication of clinical-trial data: Feedback from the European Medicines Agency workshop (Francesco Pignatti)

Presentation - European Union Clinical Trial Register and EudraCT (Ana Rodriguez)